In support of this premise, we showed here that, corrected for APACHE II scores (co-morbidities and other covariates), mechanically ventilated patients who eventually developed VAP had significantly lower levels of IL-17A levels in their ETA samples at start of mechanical ventilation compared to those who did not develop VAP. The gene discussed is IL17A; the disease is ventilator-associated pneumonia.